Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,322 | -1,001,245 | -220,368 | -13,659,530 | -428,793 |
| Depreciation Amortization | 448,197 | 1,172,843 | 348,721 | 13,670,600 | 280,874 |
| Income taxes - deferred | -41,407 | -1,145 | -1,903 | -7,840 | 41,800 |
| Accounts receivable | 25,126 | -375 | -10,252 | -49,058 | -11,172 |
| Accounts payable and accrued liabilities | 11,454 | -10,365 | -4,185 | 1,876 | 1,188 |
| Other Working Capital | 1,075 | -36,315 | 11,643 | -48,388 | -43,986 |
| Other Operating Activity | 50,234 | 170,282 | 226,365 | 281,632 | 354,079 |
| Operating Cash Flow | $294,357 | $293,680 | $350,021 | $189,292 | $193,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 740 | N/A | N/A | 2,507 | 50,000 |
| PPE Investments | -127,455 | -124,052 | -156,348 | -172,764 | -63,934 |
| Net Acquisitions | -81,904 | N/A | N/A | N/A | -78,663 |
| Purchase Of Investment | -27,875 | 0 | 0 | N/A | 10,901 |
| Purchase Sale Intangibles | -29,569 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -29,509 | 0 | 1 | 2,514 | 8,715 |
| Investing Cash Flow | $-266,003 | $-124,052 | $-156,347 | $-167,743 | $-72,981 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -550,629 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 3,085 | 8,314 | 11,132 | 12,385 | 42,591 |
| Other Financing Activity | -4,108 | -2 | -278 | -5,888 | -1,644 |
| Financing Cash Flow | $-551,652 | $8,312 | $10,854 | $6,497 | $40,947 |
| Exchange Rate Effect | 6,055 | -3,288 | 965 | -3,344 | -1,800 |
| Beginning Cash Position | 1,298,327 | 1,123,675 | 918,182 | 893,480 | 733,324 |
| End Cash Position | 781,084 | 1,298,327 | 1,123,675 | 918,182 | 893,480 |
| Net Cash Flow | $-517,243 | $174,652 | $205,493 | $24,702 | $160,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | 294,357 | 293,680 | 350,021 | 189,292 | 193,990 |
| Capital Expenditure | -127,455 | -124,052 | -156,348 | -172,764 | -63,934 |
| Free Cash Flow | 166,902 | 169,628 | 193,673 | 16,528 | 130,056 |